Matches in Wikidata for { <http://www.wikidata.org/entity/Q63401265> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q63401265 description "clinical trial" @default.
- Q63401265 description "ensayu clínicu" @default.
- Q63401265 description "klinisch onderzoek" @default.
- Q63401265 description "клінічне випробування" @default.
- Q63401265 name "A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses" @default.
- Q63401265 type Item @default.
- Q63401265 label "A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses" @default.
- Q63401265 prefLabel "A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses" @default.
- Q63401265 P1050 Q63401265-00D2F3C9-E5BE-432B-B272-31AAD924FAA3 @default.
- Q63401265 P1050 Q63401265-3457A0C0-DAAD-40DB-BF05-95A348D6E97F @default.
- Q63401265 P1050 Q63401265-BCE2EE33-AFFB-44A5-9A56-08D83719F0CC @default.
- Q63401265 P1132 Q63401265-F23F1A4B-7A93-4806-A7EE-4EF925B3820E @default.
- Q63401265 P1476 Q63401265-6564E155-CCE1-4829-BA90-68BD179F8D6D @default.
- Q63401265 P17 Q63401265-01A7E03A-7E86-4F39-8959-04E7F19AE981 @default.
- Q63401265 P17 Q63401265-3413D48F-1774-4F76-A59C-74A57EEB91E4 @default.
- Q63401265 P17 Q63401265-5915634D-A862-4496-9860-B2CA38E81CCB @default.
- Q63401265 P2899 Q63401265-1001CDE2-09F2-4C12-AE53-FD6C7B550C95 @default.
- Q63401265 P3098 Q63401265-136BAC8A-DB3D-46FC-A0E9-971742DEE125 @default.
- Q63401265 P31 Q63401265-B45E3E36-5ECD-43C6-AC9D-8485176D1C59 @default.
- Q63401265 P4135 Q63401265-71196E19-899A-4019-ACB6-E956EB60753F @default.
- Q63401265 P580 Q63401265-34976D51-70C1-4933-80B7-F7A057E0FCBC @default.
- Q63401265 P582 Q63401265-8FF4224C-4CB9-4BCD-9C6D-C662418BA9AA @default.
- Q63401265 P6099 Q63401265-6A843D57-1017-4D4E-A162-8D22EF4C0C81 @default.
- Q63401265 P6153 Q63401265-79FCDC9C-B928-4457-8B88-965C98276BB8 @default.
- Q63401265 P6153 Q63401265-873CFCEF-CC17-4DA8-8385-97B19D51A072 @default.
- Q63401265 P6153 Q63401265-9234E163-052F-43E7-BA88-4008AD0D6787 @default.
- Q63401265 P8363 Q63401265-D569A574-F39E-454A-BB7A-D79B3A42AF87 @default.
- Q63401265 P1050 Q131742 @default.
- Q63401265 P1050 Q157661 @default.
- Q63401265 P1050 Q6853 @default.
- Q63401265 P1132 "+160" @default.
- Q63401265 P1476 "A Multipart Phase 1, Double-Blind, Randomized, Placebo-Controlled, First-in-Human, Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation (Part 1); After Multi-Day Dosing (Part 2) in Healthy Subjects; and After Multiple (Ascending) Doses in Subjects With Chronic Hepatitis B (Part 3)" @default.
- Q63401265 P17 Q212 @default.
- Q63401265 P17 Q664 @default.
- Q63401265 P17 Q869 @default.
- Q63401265 P2899 "+18" @default.
- Q63401265 P3098 "NCT03439488" @default.
- Q63401265 P31 Q30612 @default.
- Q63401265 P4135 "+55" @default.
- Q63401265 P580 "2018-03-26T00:00:00Z" @default.
- Q63401265 P582 "2019-12-31T00:00:00Z" @default.
- Q63401265 P6099 Q5452194 @default.
- Q63401265 P6153 Q39988 @default.
- Q63401265 P6153 Q4403855 @default.
- Q63401265 P6153 Q492467 @default.
- Q63401265 P8363 Q78089383 @default.